Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

The Fall 2022 edition of the CBS Newsletter has been released. You can access it here.

The 38th CBS annual meeting with be held at Dalhousie University in Halifax, Nova Scotia. Call for abstracts opens December 1st, 2022, and the Early Bird registration deadline is March 1st, 2023...

The Canadian Biomaterials Society is pleased to present The 2022-2023 CBS mentorship and Professional Development Program Join The 2nd Lab and the CBS-QC Student Chapter this Friday, October 7th, 2022 at 5 00 PM for a hybrid information session about this program...

Dear CBS Members, The World Biomaterials Congress 2024 WBC2024 is soliciting recommendations for plenary speakers...

Critically sized segmental bone defects CSBDs are significant clinical challenges that require grafts for reconstruction...

Skull bone fractures and deformities are caused by a variety of conditions including Traumatic Brain Injury TBI or congenital conditions involving suture fusion...

Systemic adoptive T lymphocyte transfer is an emerging cancer immunotherapy showing tremendous promise in clinical studies, and its success lies in the ability of the antigen-experienced cytotoxic T lymphocytes cTL to access and to persist in the tumour microenvironment 1 ...

Cell therapy is increasingly used to treat various diseases such myocardial infarction. This therapeutic approach is limited however by the poor retention and diminished survival of transplanted cells in the ischemic, inflammatory and oxidative infarct microenvironment...

Geometrically complex bone grafts are needed for repairing critically-sized segmental bone defects CSBDs in which bone has been lost or damaged beyond its capacity to heal itself...